.Merck trumps profits expectations, rears purchases overview on powerful demand for leading medicines like Keytruda CNBCMerck & Co. (MRK United States) Beats Profit Projections as Keytruda Sales Rise BloombergMerck Sell: Pharma Giant Posts Strong Results, But Outlook Tumbles Short Real estate investor's Company DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck defeats revenue and also purchases requirements surrounded by Keytruda advantage, yet supplies combined full-year expectation MarketWatch.